Belongs to

• Center for Hematologic Malignancies

Types of Work

[]

[[["Meeting Abstracts",858],["Journal Articles",810],["Book Sections",62],["Conference Papers",11],["Books Whole",4]]]

[1745]

Popular keywords

• adult
• aged
• article
• cyclophosphamide
• doxorubicin
• human
• prednisone
• priority journal
• rituximab
• vincristine

Recent Works

1. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma

   Journal Article

   Timmerman, J.; Herbaux, C.; Ribrag, V.; Zelenetz, A. D.; Houot, R.; Neelapu, S. S.; Logan, T.; Lossos, I. S.; Urba, W.; Salles, G.; more...
   American Journal of Hematology (2020)

   Fulltext@MSK | Save
2. Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

   Meeting Abstract

   Abramson, J.; Palomba, M. L.; Gordon, L.; Lunning, M.; Wang, M.; Arnason, J.; Mehta, A.; Purev, E.; Maloney, D.; Andreadis, C.; more...
   Oncology Research and Treatment (2020)

   Fulltext@MSK | Save
3. Clonal hematopoiesis (CH) in angioimmunoblastic T-cell lymphoma (AITL) with divergent evolution to myeloid neoplasms (MNs)

   Meeting Abstract

   Lewis, N.; Petrova-Drus, K.; Epstein-Peterson, Z.; Huet, S.; Gao, Q.; Sigler, A.; Baik, J.; Kumar, A.; Horwitz, S.; Zhang, Y.; more...
   Laboratory Investigation (2020)

   Fulltext@MSK | Save